Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
Blood
|
December 2, 2006
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma
Juan Carlos Ramos, Phillip Ruiz, Lee Ratner, et al.
Haematologica
|
February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma
Joseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting
Kunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 11, 2018
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)
Juan C Ramos, Joseph A Sparano, Michelle A Rudek, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2022
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
Nusayba A Bagegni, Haeseong Park, Katlyn Kraft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047
Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.
Leukemia & Lymphoma
|
May 31, 2012
Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium
Ulas D Bayraktar, Juan Carlos Ramos, Adam Petrich, et al.
Virology
|
January 9, 2015
Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC
Megan M Romeo, Bookyung Ko, Janice Kim, et al.
Journal of Virology
|
September 29, 2004
Anti-Vpr activity of a yeast chaperone protein
Zsigmond Benko, Dong Liang, Emmanuel Agbottah, et al.
Plos One
|
January 7, 2011
The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice
Daniel A Rauch, Michelle A Hurchla, John C Harding, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
Blood
|
December 2, 2006
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma
Juan Carlos Ramos, Phillip Ruiz, Lee Ratner, et al.
Haematologica
|
February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma
Joseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting
Kunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 11, 2018
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)
Juan C Ramos, Joseph A Sparano, Michelle A Rudek, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2022
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
Nusayba A Bagegni, Haeseong Park, Katlyn Kraft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047
Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.
Leukemia & Lymphoma
|
May 31, 2012
Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium
Ulas D Bayraktar, Juan Carlos Ramos, Adam Petrich, et al.
Virology
|
January 9, 2015
Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC
Megan M Romeo, Bookyung Ko, Janice Kim, et al.
Journal of Virology
|
September 29, 2004
Anti-Vpr activity of a yeast chaperone protein
Zsigmond Benko, Dong Liang, Emmanuel Agbottah, et al.
Plos One
|
January 7, 2011
The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice
Daniel A Rauch, Michelle A Hurchla, John C Harding, et al.
Page
of 15